Page last updated: 2024-10-28

lidocaine and Vitreoretinopathy, Proliferative

lidocaine has been researched along with Vitreoretinopathy, Proliferative in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharma, T1
Gopal, L1
Parikh, S1
Shanmugam, MP1
Badrinath, SS1
Mukesh, BN1

Other Studies

1 other study available for lidocaine and Vitreoretinopathy, Proliferative

ArticleYear
Parabulbar anesthesia for primary vitreoretinal surgery.
    Ophthalmology, 1997, Volume: 104, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Drug Combination

1997